Mechanisms of cell death induced by suicide genes encoding purine nucleoside phosphorylase and thymidine kinase in human hepatocellular carcinoma cells in vitro

Hepatology

Volumn 34, Issue 3, 2001, Pages 511-518

  Krohne, Tim U ^a   Shankara, Srinivas ^b   Geissler, Michael ^a   Roberts, Bruce L ^b   Wands, Jack R ^c   Blum, Hubert E ^a   Mohr, Leonhard ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b GENZYME CORPORATION   (United States)

^c Liver Research Center Brown University Medical School   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; FLUDARABINE PHOSPHATE; GANCICLOVIR; HEAT SHOCK PROTEIN 70; PRODRUG; PROTEIN P53; PURINE NUCLEOSIDE PHOSPHORYLASE; THYMIDINE KINASE; VIRUS VECTOR;

APOPTOSIS; ARTICLE; CANCER CELL DESTRUCTION; CONTROLLED STUDY; DRUG ACTIVATION; DRUG EFFICACY; GENE THERAPY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; SUICIDE GENE;

ANTIGENS, CD95; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL DEATH; FAS LIGAND PROTEIN; GENE THERAPY; HSP70 HEAT-SHOCK PROTEINS; HUMANS; LIVER NEOPLASMS; MEMBRANE GLYCOPROTEINS; PURINE-NUCLEOSIDE PHOSPHORYLASE; THYMIDINE KINASE; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034868947     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.26749     Document Type: Article

References (53)

1. Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression
2. Gene therapy of hepatoma: Bystander effects and non-apoptotic cell death induced by thymidine kinase and ganciclovir
3. In vivo gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene
4. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene
5. Rabbit cytochrome P450 4B1: A novel prodrug activating gene for pharmacogene therapy of hepatocellular carcinoma
6. Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the Escherichia coli purine nucleoside phosphorylase gene
7. Rising incidence of hepatocellular carcinoma in the United States
8. The increasing incidence of hepatocellular carcinoma
9. Treatment of hepatocellular carcinoma
10. Combined use of tamoxifen, cyclosporin A, and verapamil for modulating multidrug resistance in human hepatocellular carcinoma cell lines
11. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
12. p53 mutation in hepatocellular carcinoma after aflatoxin exposure
13. Suicide genes: Past, present and future perspectives
14. Apoptosis or necrosis for tumor immunotherapy: What's in a name?
15. Life, death, and the pursuit of apoptosis
16. Apoptosis in cancer therapy: Crossing the threshold
17. Apoptosis, p53, and tumor cell sensitivity to anticancer agents
18. p53 promotes selection for Fas-mediated apoptotic resistance
19. Altered mechanisms of apoptosis in colon cancer: Fas resistance and counterattack in the tumor-immune conflict
20. Deficient activation of CD95 (APO-1/Fas)-mediated apoptosis: A potential factor of multidrug resistance in human renal cell carcinoma
21. Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells
22. Mitochondrial amplification of death signals determines thymidine kinase/ganciclovir-triggered activation of apoptosis
23. Involvement of Fas (CD95/APO-1) and Fas ligand in apoptosis induced by ganciclovir treatment of tumor cells transduced with herpes simplex virus thymidine kinase
24. Ganciclovir chemoablation of herpes thymidine kinase suicide gene-modified tumors produces tumor necrosis and induces systemic immune responses
25. Generation of an anti-tumour immune response in a non-immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Thl-like profile of intratumoural cytokine expression
26. Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component
27. A "distant" bystander effect of suicide gene therapy: Regression of nontransduced tumors together with a distant transduced tumor
28. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression
29. Is cancer dangerous to the immune system?
30. Heat shock proteins transfer peptides during antigen processing and CTL priming
31. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides
32. Heat shock protein 70 induced during tumor cell killing induces Thl cytokines and targets immature dendritic cell precursors to enhance antigen uptake
33. Relative efficiency of tumor cell killing in vitro by two enzyme-prodrug systems delivered by identical adenovirus vectors
34. Tumor cell bystander killing in colonic carcinoma utilizing the Escherichia coli DeoD gene to generate toxic purines
35. Bystander killing of melanoma cells using the human tyrosinase promoter to express the Escherichia coli purine nucleoside phosphorylase gene
36. Cell to cell contact is not required for bystander cell killing by Escherichia coli purine nucleoside phosphorylase
37. Metabolism and metabolic actions of 6-methylpurine and 2-fluoroadenine in human cells
38. APO-1 (CD95)-dependent and -independent antigen receptor-induced apoptosis in human T and B cell lines
39. Ganciclovir-induced ablation non-proliferating thyrocytes expressing herpesvirus thymidine kinase occurs by p53-independent apoptosis
40. Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases
41. S- and G2-phase cell cycle arrests and apoptosis induced by ganciclovir in murine melanoma cells transduced with herpes simplex virus thymidine kinase
42. Increased bax expression is associated with cell death induced by ganciclovir in a herpes thymidine kinase gene-expressing glioma cell line
43. Irreversible G2-M arrest and cytoskeletal reorganization induced by cytotoxic nucleoside analogues
44. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs
45. Cell surface trafficking of Fas: A rapid mechanism of p53-mediated apoptosis
46. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53
47. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene
48. The "bystander effect": Association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice
49. Heat shock proteins, tumor immunogenicity and antigen presentation: An integrated view
50. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
51. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes
52. Antigen-presenting cells that phagocytose apoptotic tumor-derived cells are potent tumor vaccines
53. Immunogenicity of apoptotic cells in vivo: Role of antigen load, antigen-presenting cells, and cytokines